ArticleAnnals of translational medicine2020
An artificial intelligent platform for live cell identification and the detection of cross-contamination.
Article in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 9 citations in OpenAlex.
- AI-Assisted Cell Culture System.Methods in molecular biology (Clifton, N.J.) · 2025Article
- Label-free live cell recognition and tracking for biological discoveries and translational applications.Npj imaging · 2024Review
- Article
- LiveCellMiner: A new tool to analyze mitotic progression.PloS one · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAbout 30% of cell lines have been cellular cross-contaminated and misidentification, which can result in invalidated experimental results and unusable therapeutic products. Cell morphology under the microscope was observed routinely, and further DNA sequencing analysis was performed periodically to verify cell line identity, but the sequencing analysis was costly, time-consuming, and labor intensive. The purpose of this study was to construct a novel artificial intelligence (AI) technology for "cell face" recognition, in which can predict DNA-level identification labels only using cell images.
methodsSeven commonly used cell lines were cultured and co-cultured in pairs (totally 8 categories) to simulated the situation of pure and cross-contaminated cells. The microscopy images were obtained and labeled of cell types by the result of short tandem repeat profiling. About 2 million patch images were used for model training and testing. AlexNet was used to demonstrate the effectiveness of convolutional neural network (CNN) in cell classification. To further improve the feasibility of detecting cross-contamination, the bilinear network for fine-grained identification was constructed. The specificity, sensitivity, and accuracy of the model were tested separately by external validation. Finally, the cell semantic segmentation was conducted by DilatedNet.
resultsThe cell texture and density were the influencing factors that can be better recognized by the bilinear convolutional neural network (BCNN) comparing to AlexNet. The BCNN achieved 99.5% accuracy in identifying seven pure cell lines and 86.3% accuracy for detecting cross-contamination (mixing two of the seven cell lines). DilatedNet was applied to the semantic segment for analyzing in single-cell level and achieved an accuracy of 98.2%.
conclusionsThe deep CNN model proposed in this study has the ability to recognize small differences in cell morphology, and achieved high classification accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.